When the System Studies Itself and Finds Itself Corrupt

In December 2025, Harvard University's Health and Human Rights Journal published two companion papers examining something the mental health system has spent decades avoiding looking at directly: the structural corruption embedded in its own governance.

The papers, led by Porsdam Mann and colleagues, did not use that language casually. "Institutional corruption" is a specific analytical category. It does not mean that individual clinicians are dishonest. It means that the architecture within which clinicians operate contains incentive structures that systematically diverge from the interests of the people the system claims to serve. The divergence is not incidental. It is structural. And the Harvard team documented it with the kind of methodological precision that makes it very difficult to dismiss.

This matters to you whether you have ever seen a therapist, taken a psychiatric medication, or simply assumed that the mental health system is organised around your wellbeing. The findings do not require you to abandon trust in every clinician you have seen. They require you to understand what the system those clinicians operate within is actually optimised to do.

What the Harvard papers found

The first paper examines institutional corruption as a structural barrier to rights-based mental health reform. The central argument is precise: the global mental health governance system contains mechanisms that protect institutional interests at the expense of the people it is mandated to serve. These mechanisms are not hidden. They are embedded in the ordinary operation of knowledge production, funding allocation, regulatory design, and treatment guideline development.

The second paper maps the political economy. It documents how financial incentives and the global export of Western biomedical narratives have entrenched specific treatment approaches not because they represent the best available evidence, but because they serve the economic interests of the pharmaceutical industry and the institutional interests of the professional bodies that endorse them.

The chemical imbalance theory is the centrepiece of this analysis. For decades, the dominant public narrative about depression was that it is caused by a chemical imbalance in the brain, specifically a deficit of serotonin. That narrative drove antidepressant prescribing at civilisational scale. It was the foundation of public mental health literacy for an entire generation. And it was not supported by the evidence.

This is not a fringe claim. Moncrieff and colleagues published a comprehensive umbrella review in Molecular Psychiatry in 2022 examining the serotonin hypothesis of depression. The conclusion was unambiguous: there is no consistent evidence of an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. The narrative that shaped how hundreds of millions of people understood their own distress was not grounded in the science it claimed to represent.

The Harvard papers go further than Moncrieff. They ask the structural question: if the chemical imbalance narrative was not supported by the evidence, why did it persist for so long? And their answer is institutional corruption. The narrative served pharmaceutical revenue. The professional bodies that could have corrected it had financial relationships with the companies that benefited from it. The knowledge hierarchies that determined what counted as legitimate clinical evidence were shaped by funding flows that favoured biomedical approaches over alternatives. The system did not fail to correct the narrative. The system's incentive structure selected for the narrative's persistence.

What this is not

This is not a conspiracy theory. The Harvard team is explicit about this distinction, and it matters.

A conspiracy requires coordinated secret action by identifiable actors pursuing a shared plan. Institutional corruption does not. It is the emergent product of incentive structures that operate in the open. No one needs to sit in a room and plan it. Financial relationships between pharmaceutical companies and professional bodies are publicly documented. Funding patterns in mental health research are publicly documented. The revolving door between regulatory agencies and the industries they regulate is publicly documented. Each individual relationship looks reasonable in isolation. The corruption is in the architecture, not in any single decision.

This is the same distinction the clinical literature makes between a personality disorder and a character flaw. A personality disorder is not a moral failing. It is a structural organisation of the personality that developed in response to environmental conditions. You do not fix it by finding the person responsible and punishing them. You fix it by understanding the architecture that maintains it. Institutional corruption works the same way. The architecture maintains itself through ordinary incentive alignment. No villain required.

Why governance-level corruption reaches your clinical encounter

The Harvard papers operate at the governance level. They examine how global mental health policy is shaped, funded, and maintained. That analysis is essential, but it can feel abstract. You do not interact with global governance systems. You interact with a clinician in a room.

Here is how the governance architecture reaches that room.

Treatment guidelines are developed by professional bodies. Those bodies receive funding from pharmaceutical companies. The funding does not come with explicit instructions to recommend specific medications. It does not need to. Funding shapes what research gets conducted. What research gets conducted shapes what evidence is available. What evidence is available shapes what guidelines recommend. By the time the guideline reaches the clinician, the pharmaceutical influence is invisible. It looks like evidence-based practice. The clinician is following the guidelines in good faith. The guidelines themselves are the product of an architecture that was shaped before the clinician ever opened them.

This is not a theoretical chain. The Harvard team documents it empirically. And the mechanism has a name in clinical psychology: it is the same architecture that operates in any system where the people inside it cannot see the structure they are operating within because the structure is the medium they think through. A fish does not see the water. A clinician operating inside a guideline framework shaped by pharmaceutical funding does not see the funding. They see the guideline. They see the evidence the guideline cites. They do not see what evidence was not funded, not conducted, not available for the guideline to cite.

The result is that a clinician can be entirely competent, entirely ethical, entirely well-intentioned, and still deliver a treatment approach that serves pharmaceutical revenue more than it serves you. Not because they chose to. Because the architecture chose for them before they entered the room.

The two mandates

Every institution that interacts with vulnerable people operates under two mandates simultaneously. The first is the stated mandate: the mission, the charter, the reason the institution exists. For the mental health system, this is the care and treatment of psychological distress.

The second is the operational mandate: the set of behaviours the institution must perform to maintain its own existence. This includes securing funding, maintaining professional legitimacy, defending regulatory territory, and managing reputational risk. These are not illegitimate activities. Every institution must do them to survive. The problem arises when the operational mandate and the stated mandate diverge, and the institution lacks the structural capacity to recognise the divergence.

The Harvard papers document this divergence at the governance level. The stated mandate of global mental health governance is rights-based, person-centred care. The operational mandate, as documented through the institutional corruption analysis, is the maintenance of biomedical dominance, pharmaceutical revenue streams, and professional knowledge hierarchies. When these two mandates conflict, the operational mandate wins. Not always. Not in every encounter. But structurally, consistently, and predictably.

This is not unique to mental health. It is the structural logic of institutional operation. What makes it particularly consequential in mental health is that the people on the receiving end of the system are, by definition, in states of psychological vulnerability. They are less equipped to recognise when the system's operational mandate has overridden its stated mandate. They are more likely to interpret institutional behaviour as care even when it is self-protection. They are more likely to blame themselves when the system fails them. The vulnerability that brings them into contact with the system is the same vulnerability that makes them unable to see the system clearly.

What the system cannot teach you

The mental health system cannot teach you to see its own structural corruption. This is not a moral failure. It is a logical impossibility. A system that is maintained by institutional corruption cannot produce the literacy that would make that corruption visible to the people it affects. If it could, the corruption would not persist.

This is the gap the Harvard papers identify at the governance level. And it is the gap that exists at the individual level, in every clinical encounter where a person sits across from a clinician and assumes that the framework being applied to their distress is organised around their interests.

The framework may be. The clinician may be. The architecture within which both operate may not be.

Understanding this does not require you to distrust your clinician. It requires you to hold two things simultaneously: that a person can be genuinely trying to help you, and that the system they operate within can contain structural incentives that are not aligned with your wellbeing. Both can be true at the same time. The Harvard papers demonstrate that they are.

What institutional literacy gives you

The reason this matters is not to make you angry at the mental health system. Anger is a response, not a strategy. The reason it matters is to give you a framework for navigating institutional encounters with your eyes open.

When a clinician recommends a treatment approach, you can ask: what guideline is this based on? Who developed the guideline? How was the evidence base for the guideline funded? These are not hostile questions. They are the same questions you would ask about any product being sold to you. The difference is that mental health treatment is not framed as a product. It is framed as care. And that framing makes the questions feel inappropriate, as though asking them is a sign of distrust rather than a sign of literacy.

That feeling, the sense that questioning the system is a symptom rather than a skill, is itself a product of the architecture. A system that frames critical engagement as pathology has built the most effective defence mechanism available: it makes the capacity to question the system look like the condition the system treats. This is not hypothetical. The Harvard papers document how critical perspectives on biomedical dominance have been marginalised within governance structures. At the individual level, the same mechanism operates when a patient's questioning of their diagnosis or treatment is interpreted as resistance, lack of insight, or symptom expression.

Institutional literacy is the capacity to see this mechanism while you are inside it. Not from outside, looking in with detachment. From inside, where you are receiving treatment, feeling vulnerable, wanting to trust the person across from you, and still maintaining the structural awareness to recognise when the architecture is not serving your interests.

That is not distrust. It is the most sophisticated form of engagement available. You trust the person. You verify the structure. You hold both.

The precision required

The Harvard papers are peer-reviewed, published in a Harvard-affiliated journal, and built on documented evidence across multiple regions and governance systems. The findings are empirical. They are not structural inferences drawn from pattern observation. They are documented relationships between funding, governance, knowledge production, and treatment outcomes.

The translation to the individual clinical encounter is a structural inference. LUMINA names it as such. The governance-level corruption documented by the Harvard team does not automatically mean that every individual clinical encounter is compromised. It means the architecture contains incentive structures that create systematic risk of misalignment between institutional behaviour and patient interests. The probability of that misalignment affecting any given encounter is not quantified by the Harvard research. What is quantified is the existence and persistence of the structural conditions that make misalignment possible.

That distinction matters. It is the difference between "the system is corrupt and you cannot trust it" and "the system contains structural corruption and you need the literacy to navigate it." The first is a conclusion. The second is a capability. LUMINA builds the capability.

Sources

Porsdam Mann, S. et al. (2025). "Examining Institutional Corruption in Mental Health: A Key to Transformative Human Rights Approaches." Harvard Health and Human Rights Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC12799052/

Porsdam Mann, S. et al. (2025). "Institutional Corruption in the Political Economy of Global Mental Health: Challenges for Transformative Human Rights Praxis." Harvard Health and Human Rights Journal. https://www.hhrjournal.org/2025/12/08/institutional-corruption-in-the-political-economy-of-global-mental-health-challenges-for-transformative-human-rights-praxis/

Moncrieff, J. et al. (2022). "The serotonin theory of depression: a systematic umbrella review of the evidence." Molecular Psychiatry, 27, 3243-3256.